{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-009173","form_type":"8-K","ticker":"PLSH","cik":"0001552189","company_name":"PANACEA LIFE SCIENCES HOLDINGS, INC.","filed_at":"2024-03-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.578045+00:00","generated_at":"2026-06-05T01:31:24.278042+00:00","sec_items":["1.01","2.03"],"event_type":"debt","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Panacea Life Sciences issues 666K shares to settle $100K note payment","bullets":["Converted $100,000 note payment to 666,000 shares of common stock on March 5, 2024.","Previous conversion in Feb 2023: 540,000 shares at $0.25/sh partially repaid the $385K note.","Original $385K Senior Convertible Note issued Mar 2022 in exchange for 350 Series A Preferred shares.","Company could not fund $100K cash payment due June 30, 2023; settled via stock conversion."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-009173","json":"https://secwatch.observer/filing/0001493152-24-009173.json","markdown":"https://secwatch.observer/filing/0001493152-24-009173.md","text":"https://secwatch.observer/filing/0001493152-24-009173.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1552189/000149315224009173/0001493152-24-009173-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1552189/000149315224009173/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T01:31:24.278042+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ae7585135d3d921ef685acc0af8509e392b1824f","claim":"PANACEA LIFE SCIENCES HOLDINGS, INC. incurred convertible notes of $385,000 Senior Convertible Note with an institutional investor maturing March 3, 2022 (dated); repayment terms include a Note Payoff Agreement dated February 9, 2023.","evidence_excerpt":"the Investor exchanged 350 shares of the Company’s Series A Preferred Stock, par value $0.0001, for a Senior Convertible Note dated March 3, 2022 in the principal amount of $385,000, as amended (the “Note”). The parties have agreed that the Company will repay the Note in full pursuant to the terms of a Note Payoff Agreement dated February 9, 2023","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1552189/000149315224009173/0001493152-24-009173-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"convertible notes"},{"label":"Principal","value":"$385,000 Senior Convertible Note"},{"label":"Counterparty","value":"an institutional investor"},{"label":"Maturity","value":"March 3, 2022 (dated); repayment terms include a Note Payoff Agreement dated February 9, 2023"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"},{"claim_id":"dd8c8fc295f6fbdddf71249f0ad2da7ef84e4f77","claim":"PANACEA LIFE SCIENCES HOLDINGS, INC. entered into Share Exchange Agreement with institutional investor valued at Senior Convertible Note dated March 3, 2022 in the principal amount of $385,000, as amended (effective 2022-03-03).","evidence_excerpt":"On March 3, 2022, Panacea Life Sciences Holdings, Inc. (the “Company”) entered into a Share Exchange Agreement with an institutional investor (the “Investor”) pursuant to which the Investor exchanged 350 shares of the Company’s Series A Preferred Stock, par value $0.0001, for a Senior Convertible Note dated March 3, 2022 in the principal amount of $385,000, as amended (the “Note”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1552189/000149315224009173/0001493152-24-009173-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"notes offering"},{"label":"Counterparty","value":"institutional investor"},{"label":"Value","value":"Senior Convertible Note dated March 3, 2022 in the principal amount of $385,000, as amended"},{"label":"Effective","value":"2022-03-03"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}